scopolamine 1 MG 3 Day Transdermal System
- RxCUI
- 226552
- RxNorm name
- scopolamine 1 MG 3 Day Transdermal System
- Display name
- scopolamine 1 MG 3 Day Transdermal System
- Full name
- scopolamine 1 MG 3 Day Transdermal System
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:47
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Scopolamine | SCOPOLAMINE | Rhodes Pharmaceuticals LLC | ba5a1237-4d23-441a-808e-96b97045fbe2 | 2026-05-06 | Warnings, Adverse reactions | 226552 |
| Scopolamine | SCOPOLAMINE | NuCare Pharmaceuticals, Inc. | 51289d8b-f7e3-a3e0-e063-6294a90add43 | 2026-05-06 | Warnings, Adverse reactions | 226552 |
| Scopolamine | SCOPOLAMINE | Bryant Ranch Prepack | 5aa64f85-ae52-4a86-a894-a4e536fbe4ad | 2026-04-16 | Warnings, Adverse reactions | 226552 |
| Scopolamine | SCOPOLAMINE | Bryant Ranch Prepack | dd031a59-6b8c-49b1-9b4d-e7a7b75e3801 | 2026-04-16 | Warnings, Adverse reactions | 226552 |
| Scopolamine | SCOPOLAMINE | Bryant Ranch Prepack | 8d53ee59-e0ef-4332-a6d6-0ac5a6c21b55 | 2026-04-16 | Warnings, Adverse reactions | 226552 |
| Scopolamine | SCOPOLAMINE | Bryant Ranch Prepack | a472ee74-76a7-470f-8564-9018940a82e8 | 2026-03-16 | Warnings, Adverse reactions | 226552 |
| Scopolamine | SCOPOLAMINE | Ingenus Pharmaceuticals, LLC | 2a6f9aaf-a70a-481f-a82b-1dcaaadc185b | 2025-12-04 | Warnings, Adverse reactions | 226552 |
| Scopolamine | SCOPOLAMINE | Zydus Pharmaceuticals USA Inc. | 62d8332e-b8d2-4d13-8071-978d57e51928 | 2025-08-23 | Warnings, Adverse reactions | 226552 |
| Scopolamine | SCOPOLAMINE | Zydus Lifesciences Limited | 016df9f3-61d5-45e9-b1d6-791a5d2f26d5 | 2025-08-23 | 226552 | |
| Scopolamine Transdermal System | SCOPOLAMINE TRANSDERMAL SYSTEM | Bryant Ranch Prepack | 8455ce88-1270-440b-b62e-fe5fef1415ac | 2025-07-31 | Warnings, Adverse reactions | 226552 |
| Scopolamine | SCOPOLAMINE | Mylan Pharmaceuticals Inc. | 163accb7-45e6-4d97-844d-72b606677008 | 2025-07-08 | Warnings, Adverse reactions | 226552 |
| scopolamine | SCOPOLAMINE | Actavis Pharma, Inc. | 800b6421-48eb-47f5-b255-c12f75e59068 | 2025-06-12 | Warnings, Adverse reactions | 226552 |
| Transderm Scop | SCOPOLAMINE | Baxter Healthcare Corporation | b877a694-a1d0-4280-937a-a06820b12a88 | 2025-06-10 | Warnings, Adverse reactions | 226552 |
| Scopolamine Transdermal System | SCOPOLAMINE TRANSDERMAL SYSTEM | Padagis Israel Pharmaceuticals Ltd | cb93bfad-3e37-4a27-92f6-f21703ae7bdf | 2025-05-31 | Warnings, Adverse reactions | 226552 |
| Scopolamine | SCOPOLAMINE | Amneal Pharmaceuticals NY LLC | 48e6e53a-d904-475b-84dd-6068cc0cb36b | 2025-05-01 | Warnings, Adverse reactions | 226552 |
| scopolamine | SCOPOLAMINE | A-S Medication Solutions | 5c232a94-0842-4efc-98a6-9d23e3b15a76 | 2024-07-05 | Warnings, Adverse reactions | 226552 |
| Scopolamine Trandermal System | SCOLOPAMINE TRANSDERMAL SYSTEM | Bryant Ranch Prepack | 81c57d46-1617-4295-8a60-acb7e365551c | 2024-06-05 | Warnings, Adverse reactions | 226552 |
| Scopolamine Trandermal System | SCOLOPAMINE TRANSDERMAL SYSTEM | Bryant Ranch Prepack | 1099a330-fcb8-4acd-9ef8-525024c6b9d6 | 2024-05-30 | Warnings, Adverse reactions | 226552 |
| Scopolamine Trandermal System | SCOLOPAMINE TRANSDERMAL SYSTEM | Bryant Ranch Prepack | c89cc74e-9506-48e5-bbb7-26b454b498aa | 2024-05-30 | Warnings, Adverse reactions | 226552 |
| Scopolamine Trandermal System | SCOLOPAMINE TRANSDERMAL SYSTEM | Bryant Ranch Prepack | 69401d6f-3d18-48b0-b28c-a578c9834f32 | 2024-01-05 | Warnings, Adverse reactions | 226552 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 1099a330-fcb8-4acd-9ef8-525024c6b9d6 | scopolamine 1 MG 3 Day Transdermal System [PSN] · 72 HR scopolamine 0.0139 MG/HR Transdermal System [SCD] · scopolamine 0.0139 MG/HR 72 HR Transdermal Patch [SY] · scopolamine 0.3336 MG/Day 72 HR Transdermal Patch [SY] · scopolamine 1.3 MG 3 Day Transdermal System [SY] | 5 | 107 | These highlights do not include all the information needed to use SCOPOLAMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for SCOPOLAMINE TRANSDERMAL SYSTEM . SCOPOLAMINE transdermal system 1 mg/3 days Initial U.S. Approval: 1979 | 20240530 |
| 81c57d46-1617-4295-8a60-acb7e365551c | scopolamine 1 MG 3 Day Transdermal System [PSN] · 72 HR scopolamine 0.0139 MG/HR Transdermal System [SCD] · scopolamine 0.0139 MG/HR 72 HR Transdermal Patch [SY] · scopolamine 0.3336 MG/Day 72 HR Transdermal Patch [SY] · scopolamine 1.3 MG 3 Day Transdermal System [SY] | 5 | 106 | These highlights do not include all the information needed to use SCOPOLAMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for SCOPOLAMINE TRANSDERMAL SYSTEM . SCOPOLAMINE transdermal system 1 mg/3 days Initial U.S. Approval: 1979 | 20240605 |
| c89cc74e-9506-48e5-bbb7-26b454b498aa | scopolamine 1 MG 3 Day Transdermal System [PSN] · 72 HR scopolamine 0.0139 MG/HR Transdermal System [SCD] · scopolamine 0.0139 MG/HR 72 HR Transdermal Patch [SY] · scopolamine 0.3336 MG/Day 72 HR Transdermal Patch [SY] · scopolamine 1.3 MG 3 Day Transdermal System [SY] | 5 | 106 | These highlights do not include all the information needed to use SCOPOLAMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for SCOPOLAMINE TRANSDERMAL SYSTEM. SCOPOLAMINE transdermal system 1 mg/3 days Initial U.S. Approval: 1979 | 20240530 |
| 69401d6f-3d18-48b0-b28c-a578c9834f32 | scopolamine 1 MG 3 Day Transdermal System [PSN] · 72 HR scopolamine 0.0139 MG/HR Transdermal System [SCD] · scopolamine 0.0139 MG/HR 72 HR Transdermal Patch [SY] · scopolamine 0.3336 MG/Day 72 HR Transdermal Patch [SY] · scopolamine 1.3 MG 3 Day Transdermal System [SY] | 5 | 104 | These highlights do not include all the information needed to use SCOPOLAMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for SCOPOLAMINE TRANSDERMAL SYSTEM . SCOPOLAMINE transdermal system 1 mg/3 days Initial U.S. Approval: 1979 | 20240105 |
| a472ee74-76a7-470f-8564-9018940a82e8 | scopolamine 1 MG 3 Day Transdermal System [PSN] · 72 HR scopolamine 0.0139 MG/HR Transdermal System [SCD] · scopolamine 0.0139 MG/HR 72 HR Transdermal Patch [SY] · scopolamine 0.3336 MG/Day 72 HR Transdermal Patch [SY] · scopolamine 1.3 MG 3 Day Transdermal System [SY] | 5 | 102 | These highlights do not include all the information needed to use SCOPOLAMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for SCOPOLAMINE TRANSDERMAL SYSTEM. SCOPOLAMINE transdermal system Initial U.S. Approval: 1979 | 20260316 |
| 5aa64f85-ae52-4a86-a894-a4e536fbe4ad | scopolamine 1 MG 3 Day Transdermal System [PSN] · 72 HR scopolamine 0.0139 MG/HR Transdermal System [SCD] · scopolamine 0.0139 MG/HR 72 HR Transdermal Patch [SY] · scopolamine 0.3336 MG/Day 72 HR Transdermal Patch [SY] · scopolamine 1.3 MG 3 Day Transdermal System [SY] | 5 | 101 | These highlights do not include all the information needed to use SCOPOLAMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for SCOPOLAMINE TRANSDERMAL SYSTEM. SCOPOLAMINE transdermal system Initial U.S. Approval: 1979 | 20260416 |
| 8d53ee59-e0ef-4332-a6d6-0ac5a6c21b55 | scopolamine 1 MG 3 Day Transdermal System [PSN] · 72 HR scopolamine 0.0139 MG/HR Transdermal System [SCD] · scopolamine 0.0139 MG/HR 72 HR Transdermal Patch [SY] · scopolamine 0.3336 MG/Day 72 HR Transdermal Patch [SY] · scopolamine 1.3 MG 3 Day Transdermal System [SY] | 5 | 101 | These highlights do not include all the information needed to use SCOPOLAMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for SCOPOLAMINE TRANSDERMAL SYSTEM. SCOPOLAMINE transdermal system Initial U.S. Approval: 1979 | 20260416 |
| dd031a59-6b8c-49b1-9b4d-e7a7b75e3801 | scopolamine 1 MG 3 Day Transdermal System [PSN] · 72 HR scopolamine 0.0139 MG/HR Transdermal System [SCD] · scopolamine 0.0139 MG/HR 72 HR Transdermal Patch [SY] · scopolamine 0.3336 MG/Day 72 HR Transdermal Patch [SY] · scopolamine 1.3 MG 3 Day Transdermal System [SY] | 5 | 101 | These highlights do not include all the information needed to use SCOPOLAMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for SCOPOLAMINE TRANSDERMAL SYSTEM. SCOPOLAMINE transdermal system Initial U.S. Approval: 1979 | 20260416 |
| 8455ce88-1270-440b-b62e-fe5fef1415ac | scopolamine 1 MG 3 Day Transdermal System [PSN] · 72 HR scopolamine 0.0139 MG/HR Transdermal System [SCD] · scopolamine 0.0139 MG/HR 72 HR Transdermal Patch [SY] · scopolamine 0.3336 MG/Day 72 HR Transdermal Patch [SY] · scopolamine 1.3 MG 3 Day Transdermal System [SY] | 5 | 101 | These highlights do not include all the information needed to use SCOPOLAMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for SCOPOLAMINE TRANSDERMAL SYSTEM. SCOPOLAMINE transdermal system Initial U.S. Approval: 1979 | 20250731 |
| b877a694-a1d0-4280-937a-a06820b12a88 | scopolamine 1 MG 3 Day Transdermal System [PSN] · 72 HR scopolamine 0.0139 MG/HR Transdermal System [SCD] · scopolamine 0.0139 MG/HR 72 HR Transdermal Patch [SY] · scopolamine 0.3336 MG/Day 72 HR Transdermal Patch [SY] · scopolamine 1.3 MG 3 Day Transdermal System [SY] | 5 | 20 | These highlights do not include all the information needed to use TRANSDERM SCŌP safely and effectively. See full prescribing information for TRANSDERM SCŌP. TRANSDERM SCŌP (scopolamine transdermal system) Initial U.S. Approval: 1979 | 20250610 |
| 2a6f9aaf-a70a-481f-a82b-1dcaaadc185b | scopolamine 1 MG 3 Day Transdermal System [PSN] · 72 HR scopolamine 0.0139 MG/HR Transdermal System [SCD] · scopolamine 0.0139 MG/HR 72 HR Transdermal Patch [SY] · scopolamine 0.3336 MG/Day 72 HR Transdermal Patch [SY] · scopolamine 1.3 MG 3 Day Transdermal System [SY] | 5 | 12 | These highlights do not include all the information needed to use SCOPOLAMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for SCOPOLAMINE TRANSDERMAL SYSTEM. SCOPOLAMINE transdermal system Initial U.S. Approval: 1979 | 20251204 |
| cb93bfad-3e37-4a27-92f6-f21703ae7bdf | scopolamine 1 MG 3 Day Transdermal System [PSN] · 72 HR scopolamine 0.0139 MG/HR Transdermal System [SCD] · scopolamine 0.0139 MG/HR 72 HR Transdermal Patch [SY] · scopolamine 0.3336 MG/Day 72 HR Transdermal Patch [SY] · scopolamine 1.3 MG 3 Day Transdermal System [SY] | 5 | 12 | These highlights do not include all the information needed to use SCOPOLAMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for SCOPOLAMINE TRANSDERMAL SYSTEM. SCOPOLAMINE transdermal system Initial U.S. Approval: 1979 | 20250531 |
| 48e6e53a-d904-475b-84dd-6068cc0cb36b | scopolamine 1 MG 3 Day Transdermal System [PSN] · 72 HR scopolamine 0.0139 MG/HR Transdermal System [SCD] · scopolamine 0.0139 MG/HR 72 HR Transdermal Patch [SY] · scopolamine 0.3336 MG/Day 72 HR Transdermal Patch [SY] · scopolamine 1.3 MG 3 Day Transdermal System [SY] | 5 | 11 | These highlights do not include all the information needed to use SCOPOLAMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for SCOPOLAMINE TRANSDERMAL SYSTEM. SCOPOLAMINE transdermal system Initial U.S. Approval:1979 | 20250501 |
| 163accb7-45e6-4d97-844d-72b606677008 | scopolamine 1 MG 3 Day Transdermal System [PSN] · 72 HR scopolamine 0.0139 MG/HR Transdermal System [SCD] · scopolamine 0.0139 MG/HR 72 HR Transdermal Patch [SY] · scopolamine 0.3336 MG/Day 72 HR Transdermal Patch [SY] · scopolamine 1.3 MG 3 Day Transdermal System [SY] | 5 | 7 | These highlights do not include all the information needed to use SCOPOLAMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for SCOPOLAMINE TRANSDERMAL SYSTEM . SCOPOLAMINE transdermal system Initial U.S. Approval: 1979 | 20250708 |
| ba5a1237-4d23-441a-808e-96b97045fbe2 | scopolamine 1 MG 3 Day Transdermal System [PSN] · 72 HR scopolamine 0.0139 MG/HR Transdermal System [SCD] · scopolamine 0.0139 MG/HR 72 HR Transdermal Patch [SY] · scopolamine 0.3336 MG/Day 72 HR Transdermal Patch [SY] · scopolamine 1.3 MG 3 Day Transdermal System [SY] | 5 | 6 | These highlights do not include all the information needed to use SCOPOLAMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for SCOPOLAMINE TRANSDERMAL SYSTEM. SCOPOLAMINE transdermal system Initial U.S. Approval: 1979 | 20260506 |
| b24c2315-c947-4ad2-89fe-8dc0c45e221b | scopolamine 1 MG 3 Day Transdermal System [PSN] · 72 HR scopolamine 0.0139 MG/HR Transdermal System [SCD] · scopolamine 0.0139 MG/HR 72 HR Transdermal Patch [SY] · scopolamine 0.3336 MG/Day 72 HR Transdermal Patch [SY] · scopolamine 1.3 MG 3 Day Transdermal System [SY] | 5 | 6 | These highlights do not include all the information needed to use SCOPOLAMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for SCOPOLAMINE TRANSDERMAL SYSTEM . SCOPOLAMINE transdermal system Initial U.S. Approval: 1979 | 20230721 |
| 62d8332e-b8d2-4d13-8071-978d57e51928 | scopolamine 1 MG 3 Day Transdermal System [PSN] · 72 HR scopolamine 0.0139 MG/HR Transdermal System [SCD] · scopolamine 0.0139 MG/HR 72 HR Transdermal Patch [SY] · scopolamine 0.3336 MG/Day 72 HR Transdermal Patch [SY] · scopolamine 1.3 MG 3 Day Transdermal System [SY] | 5 | 4 | These highlights do not include all the information needed to use SCOPOLAMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for SCOPOLAMINE TRANSDERMAL SYSTEM. SCOPOLAMINE transdermal system Initial U.S. Approval: 1979 | 20250823 |
| 800b6421-48eb-47f5-b255-c12f75e59068 | scopolamine 1 MG 3 Day Transdermal System [PSN] · 72 HR scopolamine 0.0139 MG/HR Transdermal System [SCD] · scopolamine 0.0139 MG/HR 72 HR Transdermal Patch [SY] · scopolamine 0.3336 MG/Day 72 HR Transdermal Patch [SY] · scopolamine 1.3 MG 3 Day Transdermal System [SY] | 5 | 4 | These highlights do not include all the information needed to use SCOPOLAMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for SCOPOLAMINE TRANSDERMAL SYSTEM. SCOPOLAMINE transdermal system Initial U.S. Approval: 1979 | 20250612 |
| 016df9f3-61d5-45e9-b1d6-791a5d2f26d5 | scopolamine 1 MG 3 Day Transdermal System [PSN] · 72 HR scopolamine 0.0139 MG/HR Transdermal System [SCD] · scopolamine 0.0139 MG/HR 72 HR Transdermal Patch [SY] · scopolamine 0.3336 MG/Day 72 HR Transdermal Patch [SY] · scopolamine 1.3 MG 3 Day Transdermal System [SY] | 5 | 3 | SCOPOLAMINE transdermal system | 20250823 |
| 5c232a94-0842-4efc-98a6-9d23e3b15a76 | scopolamine 1 MG 3 Day Transdermal System [PSN] · 72 HR scopolamine 0.0139 MG/HR Transdermal System [SCD] · scopolamine 0.0139 MG/HR 72 HR Transdermal Patch [SY] · scopolamine 0.3336 MG/Day 72 HR Transdermal Patch [SY] · scopolamine 1.3 MG 3 Day Transdermal System [SY] | 5 | 3 | These highlights do not include all the information needed to use SCOPOLAMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for SCOPOLAMINE TRANSDERMAL SYSTEM. SCOPOLAMINE transdermal system Initial U.S. Approval: 1979 | 20240705 |
| 51289d8b-f7e3-a3e0-e063-6294a90add43 | scopolamine 1 MG 3 Day Transdermal System [PSN] · 72 HR scopolamine 0.0139 MG/HR Transdermal System [SCD] · scopolamine 0.0139 MG/HR 72 HR Transdermal Patch [SY] · scopolamine 0.3336 MG/Day 72 HR Transdermal Patch [SY] · scopolamine 1.3 MG 3 Day Transdermal System [SY] | 5 | 1 | These highlights do not include all the information needed to use SCOPOLAMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for SCOPOLAMINE TRANSDERMAL SYSTEM. SCOPOLAMINE transdermal system Initial U.S. Approval: 1979 | 20260506 |
| f6fdc88b-ea00-4694-8f21-b8d15dbb339e | scopolamine 1 MG 3 Day Transdermal System [PSN] · 72 HR scopolamine 0.0139 MG/HR Transdermal System [SCD] · scopolamine 0.0139 MG/HR 72 HR Transdermal Patch [SY] · scopolamine 0.3336 MG/Day 72 HR Transdermal Patch [SY] · scopolamine 1.3 MG 3 Day Transdermal System [SY] | 5 | 1 | Transderm Scōp | 20130326 |